Vitek Tracz is a risk-taker. He put his money into open-access publishing when free Internet journals seemed like a long shot. "Everybody promised me that open access would not succeed," recalls the scientific publisher. "They said I would go bankrupt. I thought there was a very high chance of that, myself. But it now turns out to be significantly profitable." Two years ago he sold his BioMed Central publications—there are now about 200 of them—to Berlin-based Springer for an undisclosed sum, thought to be in the region of $50-million.
Article Source: Chronicle of Higher Education